Who owns LYRA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Lyra Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lyra Therapeutics stock

Who bought or sold LYRA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Perceptive Advisors 13M $67M 0% Dec 2023
 View chart
Nantahala Capital Management 4.1M $21M 0% Dec 2023
 View chart
Point72 Asset Management 3.0M $16M 100% Dec 2023
 View chart
Citadel Advisors 2.9M $15M 0% Dec 2023
 View chart
Samsara BioCapital 2.8M $15M 0% Dec 2023
 View chart
VR Adviser 2.6M $14M 179% Dec 2023
 View chart
Rosalind Advisors 1.9M $9.9M 100% Dec 2023
 View chart
Armistice Capital 1.6M $6.1M -61% Sep 2023
 View chart
Pura Vida Investments 1.4M $5.5M 0% Sep 2023
 View chart
Ikarian Capital 1.3M $6.6M 0% Dec 2023
 View chart
Vanguard Group 1.1M $5.6M 24% Dec 2023
 View chart
Parkman Healthcare Partners 625k $2.4M 4% Sep 2023
 View chart
Millennium Management 326k $1.7M 24% Dec 2023
 View chart
Geode Capital Management 309k $1.2M 107% Sep 2023
 View chart
Ensign Peak Advisors 302k $1.2M 0% Sep 2023
 View chart
Alyeska Investment Group 241k $1.3M -35% Dec 2023
 View chart
Boothbay Fund Management 234k $915k 43% Sep 2023
 View chart
Susquehanna International 163k $637k 1270% Sep 2023
 View chart
Bank of America Corporation 145k $758k 15% Dec 2023
 View chart
Bridgeway Capital Management 142k $554k 46% Sep 2023
 View chart
Two Sigma Investments 133k $695k 708% Dec 2023
 View chart
Citigroup 124k $652k 84% Dec 2023
 View chart
Clearline Capital 119k $624k 0% Dec 2023
 View chart
Dimensional Fund Advisors 113k $590k 299% Dec 2023
 View chart
State Street Corporation 95k $372k 70% Sep 2023
 View chart
Jane Street 78k $410k 100% Dec 2023
 View chart
683 Capital Management 70k $366k 100% Dec 2023
 View chart
Northern Trust 57k $223k 92% Sep 2023
 View chart
Two Sigma Advisers 51k $266k 100% Dec 2023
 View chart
Renaissance Technologies 50k $195k -30% Sep 2023
 View chart
BlackRock 48k $186k -2% Sep 2023
 View chart
Laurion Capital Management 42k $222k 100% Dec 2023
 View chart
Schonfeld Strategic Advisors 42k $219k 100% Dec 2023
 View chart
Man Group 38k $199k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 33k $174k 97459% Dec 2023
 View chart
Barclays 33k $172k 100% Dec 2023
 View chart
Letko, Brosseau & Associates 32k $167k 0% Dec 2023
 View chart
Cubist Systematic Strategies 30k $155k 100% Dec 2023
 View chart
Balyasny Asset Management 29k $151k 100% Dec 2023
 View chart
Bank of New York Mellon 19k $98k 0% Dec 2023
 View chart
Jump Financial 17k $88k 100% Dec 2023
 View chart
Walleye Trading Advisors 15k $79k 100% Dec 2023
 View chart
Goldman Sachs Group 13k $69k 100% Dec 2023
 View chart
Two Sigma Securities 13k $67k 100% Dec 2023
 View chart
Heritage Wealth Management, Inc./Texas 10k $52k 100% Dec 2023
 View chart
Tower Research Capital 6.8k $26k 369% Sep 2023
 View chart
UBS Group 4.8k $25k 26567% Dec 2023
 View chart
Royal Bank of Canada 3.3k $17k 0% Dec 2023
 View chart
Qube Research & Technologies 3.3k $13k 100% Sep 2023
 View chart
Advisor Group Holdings 2.0k $11k 33% Dec 2023
 View chart
Simplex Trading 1.2k $6.0k 1292% Dec 2023
 View chart
Brian McDonald 1.2k $4.5k 100% Sep 2023
 View chart
Point72 Asia 653.00 $3.4k 100% Dec 2023
 View chart
Rhumbline Advisers 296.00 $1.6k 0% Dec 2023
 View chart
Wells Fargo & Company 247.00 $1.3k 12% Dec 2023
 View chart
Group One Trading 200.00 $782.000000 100% Sep 2023
 View chart

Who sold out of Lyra Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Soleus Capital Management Sep 2023 592k $2.3M
Prescott Group Capital Management Sep 2023 30k $117k
Virtu Financial Sep 2023 20k $77k
Ameliora Wealth Management Sep 2023 750.00 $2.9k
Morgan Stanley Jun 2023 510.00 $2.1k
Us Bancorp Sep 2023 500.00 $2.0k
Signature Sep 2023 500.00 $2.0k